UBS analyst Rory McKenzie upgraded Adecco (AHEXY) to Neutral from Sell with a price target of CHF 21, down from CHF 22. The firm sees the company’s earnings stabilizing in the near-term.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AHEXY:
- Adecco Group Earnings Call Highlights Profitable Turnaround
- Adecco price target lowered to CHF 21 from CHF 22.50 at Morgan Stanley
- Balanced Risk-Reward and Margin Pressures Justify Hold Rating on Adecco
- AHEXY Earnings this Week: How Will it Perform?
- Adecco announces acquisition of Advantis Medical Staffing